4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-24-004035
CVP, EMEACLA and JAPAC sold 14,400 shares at $91.68 ($1,320,149)
- CVP, EMEACLA and JAPAC acquired 14,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lemercier Jean-Luc M · CVP, EMEACLA and JAPAC
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +14,400 | $36.75 | $529,200 | 187,983.78 | D |
| 2024-03-11 | Sale : show line 2 in the form 10b5-1 | −14,400 | $91.68 | $1,320,149 | 173,583.78 | D |
| Open-market sales · 14,400 sh · avg $91.68 · $1,320,149 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2024-03-11 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −14,400 | $36.75 | 2024-05-10 | 14,400 | 28,800 | D |
Loading xslF345X05/doc4.xml…